Legend Biotech Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.3% | +75.2% | +19.6% | -40.1% | -8.4% | +7.4% | +230.6% | -65.3% | +45.7% | -18.2% | +128.9% | +6.0% | -71.0% | +128.6% | +1.0% | +31.5% | +101.8% | +30.9% | -17.2% | +18.3% | +98.4% | -14.1% | +16.4% | +4.6% | +30.8% | +6.8% | +12.5% | -0.4% | +27.0% | – | |
| – | – | – | – | – | – | – | – | +0.0% | – | – | – | +0.0% | -79.2% | +667.3% | -78.3% | +26.2% | +260.7% | -62.1% | -33.3% | +68.7% | -7.8% | +9.9% | +33.3% | -3.5% | +37.4% | +17.7% | +7.1% | +42.5% | -21.9% | – | |
| – | +0.3% | +75.2% | +19.6% | -40.1% | -8.4% | +7.4% | +230.6% | -237.8% | – | -18.2% | +128.9% | -202.6% | – | – | – | – | -7,725.6% | – | -0.7% | -16.5% | +246.7% | -23.0% | +7.5% | +9.9% | +27.0% | 0.0% | +16.5% | -29.4% | +93.6% | – | |
| – | +53.3% | +28.4% | +57.7% | -27.4% | +11.6% | +18.8% | +5.1% | +6.2% | +17.4% | -13.4% | +19.6% | -6.0% | -15.4% | +51.9% | -22.7% | +5.1% | +12.8% | +0.1% | +10.3% | -4.5% | +11.6% | -15.2% | +9.3% | -2.4% | -3.6% | +15.1% | -10.4% | -15.2% | +11.7% | – | |
| – | +45.4% | +24.0% | +2.8% | +67.5% | +31.4% | +33.9% | +51.9% | -4.7% | +5.8% | +27.6% | +45.2% | -26.2% | +42.6% | +28.8% | +14.8% | -16.8% | +25.0% | +1.3% | +2.1% | +11.2% | +10.7% | -0.1% | -3.1% | -8.0% | +3.6% | +6.5% | +6.6% | +8.0% | -17.5% | – | |
| – | +56.9% | +23.1% | +68.5% | -28.9% | +16.7% | +16.8% | +27.0% | -7.0% | +17.4% | -5.3% | +50.7% | -26.2% | -0.9% | +28.3% | -12.7% | -2.9% | +16.6% | -3.5% | +19.3% | -5.8% | +13.3% | -1.8% | +7.0% | -6.8% | +2.6% | +12.0% | +1.5% | -12.0% | +7.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -50.0% | +331.6% | +2.4% | +4,651.2% | -97.8% | +2.3% | -55.4% | -5.3% | +36.8% | +300.0% | +189.4% | +73.4% | +57.4% | +97.7% | +49.7% | +5.2% | +1.4% | +9.5% | +2.5% | -5.9% | +0.2% | +0.4% | -6.4% | -1.8% | +3.5% | +7.7% | -2.9% | +0.3% | -96.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -344.7% | – | – | – | – | – | – | |
| – | +784.2% | -98.5% | +45,120.0% | -264.0% | – | -100.6% | – | +1,722.2% | -99.9% | -349,900.0% | – | – | -84.2% | -3.2% | +0.7% | -16.3% | +126.6% | -199.3% | – | – | +4,420.0% | +1,862.4% | +220.8% | -87.4% | -67.4% | +5.8% | +1,720.8% | -89.3% | +1,758.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -483.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -269.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.